Knight Therapeutics (KHTRF) Short Interest Ratio & Short Volume $3.78 +0.09 (+2.44%) (As of 11/18/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Knight Therapeutics Short Interest DataKnight Therapeutics (KHTRF) has a short interest of 345,200 shares. This marks a 34.79% increase in short interest from the previous month. The short interest ratio (days to cover) is 119.0, indicating that it would take 119.0 days of the average trading volume of 5,958 shares to cover all short positions.Current Short Interest345,200 sharesPrevious Short Interest256,100 sharesChange Vs. Previous Month+34.79%Dollar Volume Sold Short$1.39 millionShort Interest Ratio119.0 Days to CoverLast Record DateOctober 31, 2024Today's Trading Volume6,442 sharesAverage Trading Volume5,958 sharesToday's Volume Vs. Average108% Short Selling Knight Therapeutics? Sign up to receive the latest short interest report for Knight Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKHTRF Short Interest Over TimeKHTRF Days to Cover Over TimeKHTRF Percentage of Float Shorted Over Time Ad Porter & CompanyThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly repeat itself with the AI frenzy. I urge you to watch it before you invest another cent. Again, to be clear, I’m no Chicken Little. Far from it. So go here now to read my new report The Big AI Die-Up… while you still can. Knight Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024345,200 shares $1.39 million +34.8%N/A119 $4.04 10/15/2024256,100 shares $1.07 million +17.4%N/A128.1 $4.19 9/30/2024218,100 shares $950,916.00 -0.2%N/A94.8 $4.36 9/15/2024218,600 shares $966,212.00 +5.5%N/A128.6 $4.42 8/31/2024207,300 shares $852,003.00 +1.3%N/A76.8 $4.11 8/15/2024204,600 shares $840,906.00 -2.7%N/A55.3 $4.11 Get the Latest News and Ratings for KHTRF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024210,300 shares $868,539.00 -0.8%N/A70.1 $4.13 7/15/2024211,900 shares $885,742.00 -0.4%N/A40 $4.18 6/30/2024212,700 shares $882,705.00 -2.0%N/A44.3 $4.15 6/15/2024217,000 shares $902,720.00 -3.6%N/A433.9 $4.16 5/31/2024225,000 shares $983,475.00 +4.8%N/A59.2 $4.37 5/15/2024214,700 shares $942,533.00 -3.0%N/A55.1 $4.39 4/30/2024221,400 shares $927,666.00 +2.0%N/A82 $4.19 4/15/2024217,000 shares $909,230.00 +3.8%N/A47.2 $4.19 3/31/2024209,100 shares $819,672.00 -0.1%N/A7.1 $3.92 3/15/2024209,300 shares $830,921.00 -10.4%N/A33.8 $3.97 2/29/2024233,600 shares $955,424.00 -8.1%N/A21 $4.09 2/15/2024254,300 shares $1.04 million -0.9%N/A68.7 $4.11 1/15/2024230,500 shares $965,564.50 -2.9%N/A74.3 $4.19 12/31/2023237,300 shares $939,708.00 -2.4%N/A92.4 $3.96 12/15/2023243,100 shares $940,553.90 -45.2%N/A47.7 $3.87 11/30/2023443,500 shares $1.72 million -7.7%N/A119.9 $3.88 11/15/2023480,300 shares $1.81 million -19.4%N/A64.9 $3.76 10/31/2023596,000 shares $1.94 million +103.6%N/A220.7 $3.26 10/15/2023292,800 shares $983,808.00 +11.2%N/A6.6 $3.36 9/30/2023263,400 shares $874,539.10 -32.5%N/A39.3 $3.32 9/15/2023390,400 shares $1.28 million +6.7%N/A61 $3.29 8/31/2023366,000 shares $1.25 million +16.0%N/A8715.1 $3.41 8/15/2023315,600 shares $1.04 million -8.8%N/A3156 $3.31 7/31/2023345,900 shares $1.27 million +19.7%N/A150.4 $3.66 7/15/2023289,100 shares $1.09 million -3.2%N/A321.2 $3.78 6/30/2023298,600 shares $1.08 million +42.3%N/A64.9 $3.62 6/15/2023209,900 shares $761,937.00 -51.7%N/A8.2 $3.63 5/31/2023434,300 shares $1.58 million -29.6%N/A24.3 $3.63 5/15/2023616,700 shares $2.22 million +31.1%N/A1541.8 $3.60 4/30/2023470,400 shares $1.63 million +93.2%N/A470.4 $3.46 4/15/2023243,500 shares $881,470.00 +42.6%N/A19.5 $3.62 3/31/2023170,800 shares $561,078.00 +77.4%N/A27.5 $3.29 3/15/202396,300 shares $351,495.00 -22.0%N/A53.5 $3.65 2/28/2023123,500 shares $463,495.50 -5.6%N/A19.6 $3.75The pin that pops the AI bubble (Ad)My new documentary explores the background to this pattern and how and why I believe it will almost certainly repeat itself with the AI frenzy. I urge you to watch it before you invest another cent. Again, to be clear, I’m no Chicken Little. Far from it. So go here now to read my new report The Big AI Die-Up… while you still can. 2/15/2023130,800 shares $510,460.08 -65.2%N/A1308 $3.90 1/31/2023375,700 shares $1.47 million -16.8%N/A46.4 $3.90 1/15/2023451,300 shares $1.79 million -12.5%N/A161.2 $3.96 12/30/2022515,700 shares $1.96 million +26.0%N/A13.3 $3.80 12/15/2022409,400 shares $1.58 million +69.3%N/A4094 $3.86 11/30/2022241,800 shares $961,880.40 +103.7%N/A2418 $3.98 11/15/2022118,700 shares $472,188.60 -43.1%N/A1187 $3.98 10/31/2022208,500 shares $817,737.00 +37.4%N/A2085 $3.92 10/15/2022151,700 shares $579,038.90 +31.8%N/A758.5 $3.82 9/30/2022115,100 shares $452,688.30 +142.3%N/A115.1 $3.93 9/15/202247,500 shares $220,875.00 -4.6%N/A0 $4.65 8/31/202249,800 shares $231,570.00 +20.3%N/A124.5 $4.65 8/15/202241,400 shares $194,103.90 -42.4%N/A6.2 $4.69 7/31/202271,900 shares $319,955.00 -6.5%N/A359.5 $4.45 7/15/202276,900 shares $332,208.00 -23.8%N/A256.3 $4.32 6/30/2022100,900 shares $401,582.00 -22.2%N/A1009 $3.98 6/15/2022129,600 shares $528,768.00 -19.4%N/A117.8 $4.08 5/31/2022160,700 shares $691,010.00 +10.5%N/A47.3 $4.30 5/15/2022145,400 shares $588,870.00 -2.1%N/A80.8 $4.05 4/30/2022148,500 shares $622,660.50 +2.1%N/A148.5 $4.19 4/15/2022145,500 shares $611,100.00 -51.5%N/A363.8 $4.20 3/31/2022300,100 shares $1.23 million +59.6%N/A1500.5 $4.11 3/15/2022188,000 shares $802,760.00 -8.5%N/A626.7 $4.27 2/28/2022205,500 shares $871,320.00 -6.2%N/A40.3 $4.24 2/15/2022219,000 shares $941,700.00 -33.0%N/A64.4 $4.30 1/31/2022326,900 shares $1.43 million +41.8%N/A155.7 $4.36 1/15/2022230,600 shares $968,520.00 -15.1%N/A2306 $4.20 12/31/2021271,600 shares $1.13 million -5.9%N/A39.9 $4.16 12/15/2021288,500 shares $1.15 million +5.1%N/A72.1 $4.00 11/30/2021274,400 shares $1.12 million -24.0%N/A40.4 $4.10 11/15/2021360,900 shares $1.53 million -14.1%N/A11.2 $4.23 10/29/2021420,100 shares $1.75 million +53.3%N/A131.3 $4.15 10/15/2021274,000 shares $1.18 million -38.8%N/A47.2 $4.32 9/30/2021447,700 shares $1.93 million -7.1%N/A81.4 $4.31 9/15/2021482,000 shares $2.01 million -3.2%N/A150.6 $4.16 8/31/2021497,800 shares $2.11 million -17.6%N/A54.1 $4.25 8/13/2021604,400 shares $2.73 million -6.5%N/A167.9 $4.51 7/30/2021646,700 shares $2.65 million +39.1%N/A6.4 $4.09 7/15/2021464,900 shares $1.94 million +21.9%N/A101.1 $4.18 6/30/2021381,500 shares $1.64 million -34.2%N/A5.5 $4.30 6/15/2021580,000 shares $2.52 million -16.3%N/A1933.3 $4.34 5/28/2021726,100 shares $3.15 million -11.1%N/A907.6 $4.33 5/14/2021817,000 shares $3.52 million +4.4%N/A907.8 $4.31 4/30/2021782,400 shares $3.45 million -25.9%N/A23.9 $4.40 4/15/20211,056,300 shares $4.45 million -7.3%N/A8.1 $4.21 3/31/20211,139,900 shares $4.92 million -19.0%N/A11.5 $4.31 3/15/20211,408,000 shares $5.95 million -26.0%N/A327.4 $4.23 2/26/20211,902,200 shares $8.07 million -5.1%N/A3804.4 $4.24 2/12/20212,004,500 shares $8.90 million -29.7%N/A208.8 $4.44 1/29/20212,852,200 shares $12.06 million -37.9%N/A316.9 $4.23The pin that pops the AI bubble (Ad)My new documentary explores the background to this pattern and how and why I believe it will almost certainly repeat itself with the AI frenzy. I urge you to watch it before you invest another cent. Again, to be clear, I’m no Chicken Little. Far from it. So go here now to read my new report The Big AI Die-Up… while you still can. 1/15/20213,093,500 shares $12.86 million +6.6%N/A499 $4.16 12/31/20204,594,900 shares $19.30 million +48.5%N/A216.7 $4.20 12/15/20203,093,500 shares $12.69 million +6.6%N/A499 $4.10 11/30/20202,903,000 shares $11.84 million +5.1%N/A205.9 $4.08 11/15/20202,763,400 shares $11.41 million +0.1%N/A307 $4.13 10/30/20202,761,100 shares $11.84 million +11.1%N/A13805.5 $4.29 10/15/20202,485,600 shares $10.76 million -6.1%N/A994.2 $4.33 9/30/20202,647,100 shares $11.54 million +0.6%N/A472.7 $4.36 9/15/20202,630,300 shares $12.27 million +1.6%N/A417.5 $4.67 8/31/20202,590,200 shares $12.32 million -1.3%N/A221.4 $4.76 8/14/20202,625,200 shares $13.43 million +0.7%N/A276.3 $5.12 7/31/20202,606,000 shares $13.59 million -3.9%N/A2004.6 $5.22 7/15/20202,712,700 shares $13.92 million +3.3%N/A1043.3 $5.13 6/30/20202,626,200 shares $14.05 million -0.3%N/A937.9 $5.35 6/15/20202,634,400 shares $13.22 million -2.5%N/A13172 $5.02 5/29/20202,702,300 shares $14.79 million -1.0%N/A27023 $5.47 5/15/20202,728,100 shares $14.43 million +10.0%N/A13640.5 $5.29 4/30/20202,480,300 shares $13.84 million +2.0%N/A729.5 $5.58 4/15/20202,432,900 shares $11.99 million +3.1%N/A1158.5 $4.93 3/31/20202,361,000 shares $13.43 million +8.6%N/A4722 $5.69 3/13/20202,174,400 shares $10.96 million -0.3%N/A258.9 $5.04 2/28/20202,180,000 shares $10.90 million +1.4%N/A660.6 $5.00 2/14/20202,150,300 shares $10.30 million -4.7%N/A212.9 $4.79 1/31/20202,256,500 shares $13.50 million -2.2%N/A1880.4 $5.98 1/15/20201,511,000 shares $8.69 million -9.0%N/A3022 $5.75 12/31/20191,661,200 shares $9.97 million -0.3%N/A48.7 $6.00 KHTRF Short Interest - Frequently Asked Questions What is Knight Therapeutics' current short interest? Short interest is the volume of Knight Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 345,200 shares of KHTRF short. Learn More on Knight Therapeutics' current short interest. What is a good short interest ratio for Knight Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KHTRF shares currently have a short interest ratio of 119.0. Learn More on Knight Therapeutics's short interest ratio. Is Knight Therapeutics' short interest increasing or decreasing? Knight Therapeutics saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 345,200 shares, an increase of 34.8% from the previous total of 256,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Knight Therapeutics stock? Short selling KHTRF is an investing strategy that aims to generate trading profit from Knight Therapeutics as its price is falling. KHTRF shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Knight Therapeutics? A short squeeze for Knight Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KHTRF, which in turn drives the price of the stock up even further. How often is Knight Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KHTRF, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies 1933 Industries Short Interest 4Cable TV International Short Interest 4Front Ventures Short Interest AB Science Short Interest Acreage Short Interest Acreage Short Interest Aleafia Health Short Interest Almirall Short Interest Alvotech Short Interest American Green Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:KHTRF) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | SponsoredThe Stock Powering Musk’s AI Revolution—RevealedImagine being able to invest in Tesla, PayPal, or SpaceX before the world knew their potential. Today, you ...InvestorPlace | SponsoredTrump’s EPIC Stock Market RallyPutting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Knight Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Knight Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.